J Clin Neurol.
2009 Sep;5(3):120-125. 10.3988/jcn.2009.5.3.120.
Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases
- Affiliations
-
- 1Department of Neurology, Konkuk University Medical Center, Center for Geriatric Neuroscience Research, Institute of Biomedicalscience and Technology, Konkuk University, Seoul, Korea. alzdoc@paran.com
- KMID: 2045417
- DOI: http://doi.org/10.3988/jcn.2009.5.3.120
Abstract
- The sirtuins (SIRTs) are protein-modifying enzymes that are distributed ubiquitously in all organisms. SIRT1 is a mammalian homologue of yeast nicotinamide-adenine-dinucleotide-dependent deacetylase silent information regulator 2 (known as Sir2), which is the best-characterized SIRT family member. It regulates longevity in several model organisms and is involved in several processes in mammalian cells including cell survival, differentiation, and metabolism. SIRT1 induction, either by SIRT-activating compounds such as resveratrol, or metabolic conditioning associated with caloric restriction, could have neuroprotective qualities and thus delay the neurodegenerative process, thereby promoting longevity. However, the precise mechanistic liaison between the activation of SIRT and extended healthy aging or delaying age-related diseases in humans has yet to be established.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases
- SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
- Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial
- Induced Pluripotent Stem Cells Derived CD71＋CD235a＋ Erythroblasts Were Increased by Sirtuin 1 Activator
- Animal Models of Neurodegenerative Diseases
